{"database": "lobbying", "table": "lobbying_activities", "rows": [[2461798, "48a6ce69-439d-4ac9-a93f-d28fedade2b4", "Q2", "HOLLAND & KNIGHT LLP", 18466, "ALLIANCE FOR REGENERATIVE MEDICINE", 2020, "second_quarter", "MMM", "Patient Affordability, Value and Efficiency Act; S.2543, Prescription Drug Pricing Reduction Act of 2019; \"Value Based Payment\" draft legislation; H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act; Coronavirus Aid, Relief, and Economic Security (CARES) Act (H.R. 748); Cures 2.0 legislative discussions.", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2020-07-07T13:22:59.177000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2461798"], "units": {}, "query_ms": 5.43971499428153, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}